Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Jones Cecilia sold 3,141 Agios Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 2, 2026 · Filed Apr 6, 2026
On Apr 2, 2026, Jones Cecilia (Chief Financial Officer) sold 3,141 Agios Pharmaceuticals, Inc. shares at US$34.71 for US$109K under a trading plan, leaving 54,998 shares. Filed Apr 6, 2026 (Form 4).
- Sold
- 3,141 shares
- Price
- US$34.71
- Value
- US$109K
- Holding after
- 54,998 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common stock | Option exercise | 8,500 | 58,139 | Direct | |
| Apr 2, 2026 | Common stock | Sale | 3,141 | US$34.71 | 54,998 | Direct |
Source
Related
- Agios Pharmaceuticals, Inc.
- Jones Cecilia
- Agios Pharmaceuticals, Inc. shareholders
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026